Literature DB >> 9337009

Carcinoma of the oesophagus in Ibadan.

H U Pindiga1, E E Akang, J O Thomas, P U Aghadiuno.   

Abstract

This was a retrospective analysis of 177 histologically confirmed cases of oesophageal carcinoma seen in the University College Hospital, Ibadan, Nigeria over a period of 30 years. Oesophageal carcinoma constituted 0.6 per cent of all malignant neoplasms and 1.4 cases per 1000 surgical biopsies during the study period. Dysphagia and weight loss were the most common clinical manifestations. Ninety three patients presented within one year of onset of clinical symptoms. The peak age incidence occurred in the seventh decade of life. Sex distribution was equal. The middle third of the oesophagus was the most common location of the neoplasm and the vast majority (94.5%) were squamous cell carcinomas. Achalasia of the cardia and Barrett's oesophagus were not associated with oesophageal carcinoma in this study. Regional lymph nodes and lungs were the most common sites of metastasis. Surgical complications included mediastinitis and bronchopneumonia, both occurring within seven days postoperatively. Late clinical presentation and high postoperative mortality are responsible for the persistently poor prognosis of oesophageal carcinoma despite significant advances in the diagnosis and management of these neoplasms.

Entities:  

Mesh:

Year:  1997        PMID: 9337009

Source DB:  PubMed          Journal:  East Afr Med J        ISSN: 0012-835X


  2 in total

1.  [Descriptive and analytical study of esophageal cancer in Togo].

Authors:  Bouglouga Oumboma; Lawson-Ananissoh Laté Mawuli; Bagny Aklesso; Kaaga Laconi; Redah Datouda
Journal:  Pan Afr Med J       Date:  2014-11-21

2.  Endoscopic and clinicopathological patterns of esophageal cancer in Tanzania: experiences from two tertiary health institutions.

Authors:  Mabula D McHembe; Peter F Rambau; Phillipo L Chalya; Hyasinta Jaka; Mheta Koy; William Mahalu
Journal:  World J Surg Oncol       Date:  2013-10-04       Impact factor: 2.754

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.